Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...
A Stage 4 lung cancer diagnosis at the height of Covid coincided with the dissolution of my 20-year marriage. The news landed ...
For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...
Lung cancer remains one of the leading causes of cancer deaths around the world. Among the different types of lung cancer, ...
Abstract: Early detection of lung cancer is paramount for improved patient outcomes and reduced mortality rates. This research presented an innovative methodology combining machine learning with ...
Lung cancer is the second most common malignancy in the United States. Lung cancers are broadly divided into small cell and non-small cell lung cancer (SCLC and NSCLC, respectively). SCLC is a ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results